Ipilimumab regulatory update

FDA's Oncologic Drugs Advisory Committee will meet on Dec. 2 to discuss a BLA from Bristol-Myers for ipilimumab to treat metastatic melanoma in pre-treated patients. The human mAb against CTLA-4 rece...